The director of the Provincial Securities Regulatory Bureau came to our company to investigate and guide the listing work
On the afternoon of August 10, Kuang Xiaofeng, director of Jiangxi Securities Regulatory Bureau, led a team to our company to investigate and guide the listing of enterprises. Li Zhi, Director of the Comprehensive Business Supervision Department of Jiangxi Securities Regulatory Bureau, Wang Dasheng, Member of the Standing Committee of the Municipal Party Committee and Executive Deputy Mayor, Wei Zhankui, Deputy Secretary-General of the Municipal Government, Xiao Kaiyu, Director of the Municipal Financial Office, Huang Guodong, Director of the District Management Committee, member of the District Party Working Committee and Management Committee Zhu Rongmao, deputy director of the meeting, Li Xiaojiang, deputy director of the district management committee, and Xiao Zhangluo, director of the district finance bureau, accompanied the investigation.
The research team came to the company, visited our automation control center, communicated with the person in charge of the company, and learned about the product process and market application in detail. And held a discussion and exchange on promoting the listing of enterprises.
At the symposium, Chairman Zhu Feilun reported the company's development situation, production and operation, core technology advantages, and listing progress in detail to the leaders of the research team. He also said that Yuneng Pharmaceutical will continue to strengthen its confidence, cooperate closely with various intermediaries, coordinate efficiently, and work together to promote the listing work.
Huang Guodong, director of the district management committee, said that the local government will further strengthen close communication and cooperation with enterprises, and go all out to do a good job of listing enterprises in strict accordance with the time node. At the same time, it is also hoped that the Jiangxi Securities Regulatory Bureau will provide more guidance and support in terms of corporate listing training and guidance, financial and business environment, etc., to inquire about the pulse of companies for listing, plan a roadmap, speed up the listing process, and ensure the sustainable development of listed companies.
Kuang Xiaofeng, director of Jiangxi Securities Regulatory Bureau, listened carefully to the report and gave full affirmation and encouragement to our company's achievements in the pharmaceutical industry. And according to the basic conditions of the enterprise, professional guidance for the listing of enterprises. She pointed out that promoting the listing of enterprises is the first step towards high-quality development of enterprises, which can not only effectively solve the financing problems of enterprises, but also promote enterprise system innovation, management innovation and technological innovation. Encourage enterprises to seize the opportunities in the capital market, strengthen their belief in listing, further improve their internal skills, strengthen their main business, adhere to innovation and leadership, focus on improving the research and development system, and continuously improve their core competitiveness and anti-risk capabilities, so as to create favorable conditions for companies to list on the Beijing Stock Exchange. condition. At the same time, he said that focusing on listing means focusing on development. For the difficulties and problems encountered in the development of enterprises' listing, relevant departments should try their best to help them to improve the efficiency and success rate of listing. The Provincial Securities Regulatory Bureau will continue to support the listing of enterprises in the Jinggangshan Economic and Technological Development Zone, further strengthen policy guidance, do a good job in the cultivation and guidance of backup companies, help companies accelerate their listing goals, and help the development zone's economy achieve high-quality development.
